DTC Print Ads Need Consumer-Friendly Fair Balance Information
The FDA recently published revised draft guidance on "Brief Summary: Disclosing Risk Information in Consumer-Directed Print Advertisements." (see "Disclosing Risk in DTC Print Ads:...
Pharma Profits are Driven More by Marketing Spend Than by R&D Spend
Data from Forbes for 2013 document that the profit margins of banks and pharmaceutical companies ranked the highest (see here). Both industries have outlying...
PharmaGuy’s Mission Statement à la PHARMAGEEK!
I recently attended the SMi's 7th Annual Social Media in the Pharmaceutical Industry conference in London where I met Lionel Reichardt (PHARMAGEEK). He pulled...
How High Technology Can Help Improve Pharma’s Reputation & Increase Sales
A pharma sales rep avatar
World of DTC Marketing blogger Rich Myer asked "How should pharma respond when attacked?" This was in response to the...
Drug Risk Notification Survey
This survey asked respondents to evaluate the FDA's proposed Drug Watch program as well
as the proposal for a Drug Risk Advisory System.
Some “Walter White” Pharma Sales Reps Make an “Ungodly” Amount of Money
Last Week Tonight with John Oliver is back on HBO and the pharmaceutical industry was the centerpiece of last night's show in which Oliver...
Disclosing Risk in DTC Print Ads: Introducing the “Consumer Brief Summary”
On February 4, 2004, the FDA issued long-awaited draft guidance documents designed to improve communications to consumers and health care practitioners about health conditions...
How Virtually Anyone Can Get an Rx for Amphetamine… Sorry, I Meant to Say...
After writing yesterday's blog post about Monica Seles helping Shire promote Vyvanse for Binge Eating Disorder (B.E.D.), which is a new indication for the...
Shire & Seles Team up in B.E.D. to Promote Vyvanse. Celebrity Endorsement at Its...
OMG! Is there nothing old athletes won't do for money?
Remember Monica Seles who was famously stabbed on the tennis court in 1993? No? OK,...
Look Ma! No Bong! Afrezza Inhaled Insulin Device is a Cool Gadget
UPDATE (1/5/2016): Sanofi terminated its license agreement related to the development and commercialisation of MannKind's inhaled insulin therapy Afrezza, MannKind said today (here). MannKind...
